Prescribers know how to prescribe. CannaScript tells them what — and why. AI-powered decision support with terpene-level clinical rationale. The prescriber always makes the final call.
Decision support · Not a medical device · The prescriber decides
You understand the patient. CannaScript understands the formulary. The prescriber makes every call — better informed.
One clinic subscription covers your core prescribing team — scale up with additional seats at £75/month per prescriber.
Last updated: 12 June 2026 · CannaScript Ltd
CannaScript Ltd ("CannaScript", "we", "us", "our") is a company registered in England and Wales (Company No. 17199513). Our registered office is at 195-197 Wood Street, London, E17 3NU.
We operate the CannaScript platform at cannascript.co.uk — a clinical intelligence service for UK specialist cannabis prescribers. Jordan Cooper is the director and data controller for purposes of the UK General Data Protection Regulation (UK GDPR) and the Data Protection Act 2018.
If you have any questions about how we handle your data, please contact us at hello@cannascript.co.uk.
When you register as a prescriber, we collect: your full name, email address, GMC registration number, clinic name, and the date you registered. This is necessary to verify your eligibility to use the AI Matcher and to provide the service under our contract with you.
When you log a prescription via the platform, we store: the product prescribed, the clinical indication, an anonymised patient reference (assigned by you — we never collect patient names, dates of birth, NHS numbers, or any directly identifying patient data), clinical notes (if entered), outcome, and date. These records support your CPD record-keeping and clinic analytics.
We log how prescribers use the platform — including which prescriber ran a query, when, the clinical category queried, and which products were returned — to improve the service, ensure reliability, and understand usage. This processing relies on our legitimate interest in operating and improving CannaScript. We do NOT log patient-identifiable information in these usage records; patient descriptions entered into the matcher must be anonymised, and we store only the derived clinical category, never patient names, dates of birth or NHS numbers.
If you use the patient community, we collect the username you choose, posts you publish, comments, and likes. We do not require your real name for community participation. Patient prescription records are not stored — only anonymised verification status.
We use Netlify Analytics for basic traffic statistics (page views, visitor counts). Netlify Analytics is privacy-friendly: it does not use cookies, does not track individuals across sessions, and does not share data with third-party advertising networks.
If you contact us by email, we retain your email and message content in order to respond to you. We do not add you to a marketing list without explicit consent.
| Data | Legal Basis (UK GDPR Art. 6) |
|---|---|
| Prescriber account data | Performance of contract (Art. 6(1)(b)) — necessary to provide the service |
| Prescription logs | Legitimate interests (Art. 6(1)(f)) — supporting CPD records and clinical governance; and contract performance |
| Community content | Consent (Art. 6(1)(a)) — you choose to post publicly |
| Analytics data | Legitimate interests (Art. 6(1)(f)) — understanding platform usage to improve the service |
| Email enquiries | Legitimate interests (Art. 6(1)(f)) — responding to your enquiry |
We use the following sub-processors to operate the platform. All are bound by appropriate data processing agreements.
| Processor | Purpose | Location |
|---|---|---|
| Supabase Inc. | Database hosting (prescriber accounts, prescription logs, community data) and authentication | EU (AWS Frankfurt) |
| Anthropic PBC | AI language model processing for the CBPM Matcher. Query text is sent to the API; we do not send patient-identifiable information | USA (standard SCCs apply) |
| Resend Inc. | Transactional email delivery (account notifications, contact form responses) | USA (standard SCCs apply) |
| Netlify Inc. | Website hosting and privacy-friendly analytics | USA (standard SCCs apply) |
| Data type | Retention period |
|---|---|
| Prescriber account | For the duration of your active account, plus 12 months after closure |
| Prescription logs | 3 years from date of entry (supporting CPD obligations) |
| Community posts | Until you delete them, or until your account is closed |
| Email enquiries | 12 months from the date of last correspondence |
| Analytics data | Retained by Netlify per their policy (aggregated, not personal) |
You have the following rights regarding your personal data:
To exercise any right, email hello@cannascript.co.uk. We will respond within one calendar month. You also have the right to lodge a complaint with the Information Commissioner's Office (ICO) at ico.org.uk.
CannaScript uses only essential session cookies to maintain your login state. We do not use advertising cookies, tracking pixels, or third-party marketing cookies. See our for full details.
We may update this Privacy Policy from time to time. Material changes will be communicated by email to registered prescribers. The "last updated" date at the top of this page will always reflect the current version.
Last updated: June 2026 · CannaScript Ltd
By accessing or using the CannaScript platform at cannascript.co.uk, you agree to be bound by these Terms and Conditions. If you do not agree, please do not use the platform. These terms form a legally binding agreement between you and CannaScript Ltd (Company No. 17199513), registered in England and Wales.
CannaScript is the clinical intelligence layer for UK specialist medical cannabis prescribers. The platform includes:
CannaScript is clinical intelligence layer only. It does not constitute medical advice, does not replace clinical judgement, and is not a substitute for specialist training in cannabinoid medicine.
Access to the AI Matcher, prescribing database, and CPD tools is restricted to:
By registering as a prescriber, you confirm that you hold a current, unrestricted licence to practise and that you are legally authorised to prescribe Schedule 2 controlled drugs in the UK. You must notify us immediately if your registration status changes.
The patient community is open to adult UK residents who are medical cannabis patients or caregivers.
By using the AI Matcher, you acknowledge and agree that:
You may not use CannaScript to:
We reserve the right to suspend or terminate access for breach of these terms without notice or refund.
CannaScript is offered on the following subscription plans:
| Plan | Price | Prescribers included |
|---|---|---|
| Clinic Starter | £299/month + VAT | 2 prescribers included |
| Clinic Growth | £549/month + VAT | 5 prescribers included |
| Clinic Enterprise | £799/month + VAT | Unlimited prescribers |
| Additional prescriber seat | £75/month + VAT | Per seat above included allowance |
Subscriptions are billed monthly in advance. You may cancel at any time; cancellation takes effect at the end of the current billing period. No refunds are provided for partial months. We reserve the right to change pricing with 30 days' written notice to current subscribers.
All content, design, code, AI models, and CBPM database content on CannaScript is the property of CannaScript Ltd or its licensors and is protected by UK and international intellectual property law. Nothing in these terms grants you any licence to reproduce or distribute CannaScript content beyond personal use within the platform.
You retain ownership of any clinical notes or data you enter. By entering data, you grant CannaScript Ltd a limited licence to store and process it solely for the purpose of providing the service.
To the maximum extent permitted by applicable law:
Nothing in these terms excludes liability for death or personal injury caused by our negligence, fraud, or any other liability that cannot be excluded by law.
These Terms and Conditions are governed by the laws of England and Wales. Any dispute arising from these terms shall be subject to the exclusive jurisdiction of the courts of England and Wales.
We may update these terms from time to time. We will give registered users at least 14 days' notice of material changes by email. Continued use of the platform after the effective date constitutes acceptance of the revised terms.
Questions? Contact us at hello@cannascript.co.uk.
Last updated: June 2026 · CannaScript Ltd
For our full regulatory position including our MHRA Software as a Medical Device assessment, see our page.
Important: Please read this disclaimer carefully before using the CannaScript platform. Using the platform constitutes acceptance of the limitations described below.
CannaScript is a clinical intelligence information platform. It is not registered with the Medicines and Healthcare products Regulatory Agency (MHRA) as Software as a Medical Device (SaMD) under the Medical Devices Regulations 2002 (as amended).
The platform does not diagnose conditions, does not constitute a prescription, and does not replace the clinical assessment of a qualified specialist. All outputs from the AI Matcher are informational suggestions only.
The prescribing clinician retains full and sole clinical responsibility for every prescribing decision made in connection with the use of CannaScript. CannaScript Ltd, its directors, employees, and agents accept no liability for clinical outcomes arising from reliance on platform outputs.
Prescribers must:
Terpene profiles displayed on CannaScript are estimated from strain genetics and producer specifications. They are not derived from Certificate of Analysis (COA) laboratory testing unless explicitly stated for a specific batch.
Terpene content in cannabis-based medicinal products varies between batches. Clinicians should not rely on terpene data as precise pharmacological specifications.
References to the "entourage effect" on CannaScript reflect preclinical pharmacological research and emerging observational data. The entourage effect — the proposed synergistic interaction between cannabinoids, terpenes, and other phytochemicals — has not been demonstrated in rigorous human randomised controlled trials as of the date of this disclaimer.
Clinical rationale derived from terpene and entourage effect data should be treated as a hypothesis-generating framework, not as established clinical evidence. Apply specialist judgement accordingly.
CannaScript does not replace formal clinical training in cannabinoid medicine. Prescribers are strongly encouraged to complete recognised CPD programmes in medical cannabis before prescribing CBPMs.
Relevant training is available from organisations including the Medical Cannabis Clinicians Society (MCCS), the Faculty of Pain Medicine, and other accredited providers.
Any suspected adverse reactions to cannabis-based medicinal products should be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. Healthcare professionals are encouraged to report all suspected adverse reactions, including those associated with unlicensed products.
CannaScript endeavours to maintain accurate CBPM data, pharmacy availability, and pricing information. However, this information changes frequently. We do not guarantee the accuracy, completeness, or currency of any product or pharmacy data on the platform.
Always verify product availability and current specifications directly with the dispensing pharmacy before issuing a prescription.
Last updated: June 2026 · CannaScript Ltd
Cookies are small text files placed on your device by websites you visit. They are used to remember preferences, maintain login sessions, and collect analytics data. Some cookies are essential for websites to function; others are used for tracking and advertising.
CannaScript uses a minimal, privacy-first approach to cookies. We do not use advertising cookies, tracking pixels, or third-party marketing trackers of any kind.
| Cookie type | Purpose | Duration | Third party? |
|---|---|---|---|
| Session cookies | Maintain your login state while you are actively using the platform. Required for prescriber and patient authentication via Supabase Auth. | Session (deleted when browser closes) | No — set by cannascript.co.uk |
| Netlify Analytics | Privacy-friendly, cookieless analytics. Counts page views and unique visitors without tracking individuals or storing personal data. No cookies are set. | N/A — cookieless | No tracking cookies |
CannaScript uses browser localStorage to store your session preferences and login state on your device. This data is stored locally and is not transmitted to third parties. You can clear localStorage at any time through your browser settings.
You can control and delete cookies through your browser settings. Please note that disabling session cookies will prevent you from logging in to CannaScript.
If we change our approach to cookies in the future, we will update this page and notify registered users by email if those changes are material.
Questions? Contact us at hello@cannascript.co.uk.
We aim to respond within 24 hours · hello@cannascript.co.uk
Whether you have a clinical question, a technical issue, a press enquiry, or want to discuss a partnership — we'd love to hear from you.
By submitting this form you agree to our . We will not add you to a marketing list without your explicit consent.
We aim to respond to all enquiries within 24 hours on business days (Monday–Friday, excluding UK public holidays).
For GDPR or data rights requests, we will acknowledge your request within 72 hours and respond fully within one calendar month, in accordance with UK GDPR requirements.
Last updated: June 2026 · CannaScript Ltd
CannaScript is not a medical device and does not require MHRA Software as a Medical Device (SaMD) registration.
The MHRA's guidance on SaMD distinguishes between two categories of clinical software:
CannaScript falls firmly in the second category. The platform provides clinical information and decision support to licensed specialist prescribers. It does not diagnose, prescribe, or autonomously determine treatment. Every prescribing decision remains with the licensed specialist prescriber.
This is consistent with how similar clinical information tools operate in the UK — including drug interaction checkers, formulary browsers, and clinical calculators — none of which require MHRA SaMD registration.
CannaScript is built with clinical safety as a first principle. The following safeguards are active on every use of the platform:
CannaScript is seeking a formal legal opinion from a specialist healthcare regulatory solicitor confirming our SaMD positioning. This will be completed before we move beyond the trial and early access stage.
We will publish a summary of the outcome on this page when received.
If you have a clinical governance concern about CannaScript, please contact us directly at hello@cannascript.co.uk. We take all clinical safety concerns seriously and will respond within 24 hours.
CannaScript does not replace the statutory obligation of prescribers to report adverse events. Any suspected adverse reactions to cannabis-based medicinal products must be reported via the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk.
CannaScript is an information platform only. We do not prescribe, dispense or sell cannabis-based medicines. © 2026 CannaScript Ltd
Khiron Gorilla Glue #4 · M. Kaur · Chronic pain
They'll receive an email link to set up their account. The CannaScript team verifies GMC before access goes live — usually within 24 hours.
Add to your prescribing record — builds your CPD portfolio
How the community sees you — your name and condition only, never your full identity
Upload proof of your UK medical cannabis prescription. We verify manually within 24 hours — your prescription details are never stored or shared.
Your post helps other patients make better decisions